StockData
CytomX Therapeutics, Inc. logo

CytomX Therapeutics, Inc. (CTMX) stock

CTMXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 8/30
$1.88−0.06 (-3.09%)

Close on Nov 18, 2026Market cap $409.65MP/E –Yield –

CytomX Therapeutics pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

CytomX Therapeutics's pe ratio was 14.2× on Jan 30, 2026, against 5.0× a year earlier.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Jan 30, 202614.2×+3.6
2025Dec 31, 202510.7×+4.6
2024Dec 31, 20246.1×–

More CytomX Therapeutics figures

See a number that looks wrong?